Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)

Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)

US Patent 6132967 · Granted Oct 17, 2000

Estimated economic value: $4,811,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for inducing immune responses2025
Coronavirus vaccine compositions and methods2025
Adeno-associated virus compositions for restoring HBB gene function and methods 2025
Adeno-associated virus compositions for restoring PAH gene function and methods 2025
Compositions and methods for dengue virus chimeric constructions in vaccines2025
CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of2024
Compositions and methods for dengue virus chimeric constructions in vaccines2024
Adeno-associated virus compositions for restoring F8 gene function and methods o2024
Compositions and methods for modulating MECP2 expression2023
Compositions and methods for inducing immune responses2023
Coronavirus vaccine compositions and methods2023
Secure content access system2023